Another study utilizing CS-6253, a peptide mimicking the C-terminus of ApoE that functions to enhance the recycling of ABCA1, has demonstrated promising results in reducing AD-related pathology in animal models [350]. This evidence concerns the gene ABCA1 and Alzheimer disease.